GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Price-to-Funds-From-Operations

LOBEF (Lobe Sciences) Price-to-Funds-From-Operations : (As of Apr. 15, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Lobe Sciences Business Description

Traded in Other Exchanges
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.